Melatonin provides protection against heat stroke-induced myocardial injury in male rats

The Journal of Pharmacy and Pharmacology
Xiaojing LinChien-Ming Chao

Abstract

This study aimed to investigate the cardioprotective effects of melatonin on heat stroke (HS) induced acute myocardial infarction in rats and to explore the underlying mechanisms. Myocardial injury was induced by subjecting the anaesthetized rats to a high ambient temperature of 43°C for 70 min. Such a high ambient temperature caused hyperthermia, hypotension and myocardial injury in rats. Rats were treated with melatonin (3 mg/kg) intravenously one hour before and followed by an additional dose immediately after heat stress. At the onset of HS, animals displayed myocardial injury evidenced by increased levels of cardiac damage indicators (e.g. total lactate dehydrogenase, cardiac troponin I and creatine kinase-MB), increased cardiac damage scores and suppressed left ventricular performance. Animals with HS also had increased cardiac oxidative stress evidenced by increased levels of lipid peroxidation (e.g. increased thiobarbituric acid reactive substances) and decreased levels of antioxidant enzymes (e.g. superoxide dismutase, catalase and reduced glutathione) and activated inflammation (e.g. increased levels of interleukin-6 and tumour necrosis factor-α). Pretreatment with melatonin significantly reversed the HS-induced myoca...Continue Reading

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
Jun 1, 1972·Analytical Biochemistry·A K Sinha
Aug 8, 1998·Annals of Internal Medicine·J E DematteI M Ndukwu
Apr 24, 2001·Journal of Pineal Research·C C WuM H Yen
May 1, 1959·Archives of Biochemistry and Biophysics·G L ELLMAN
Feb 1, 1961·The American Journal of Medicine·J P KNOCHELK G BARRY
Nov 15, 2003·Science·Michelle L MonjeTheo D Palmer
Jun 3, 2004·Circulation·James T Willerson, Paul M Ridker
Oct 22, 2005·Journal of Applied Physiology·Lisa R LeonDavid A DuBose
Aug 10, 2006·Clinical and Experimental Pharmacology & Physiology·Sheng-Hsien ChenMao-Tsun Lin
May 7, 2008·European Journal of Applied Physiology·Kun-Hung ShenChing-Ping Chang
Mar 10, 2010·Journal of Pineal Research·Debasri MukherjeeDebasish Bandyopadhyay
May 4, 2010·Journal of Critical Care·Venkataramanujan SrinivasanDaniel P Cardinali
Aug 11, 2010·Biochemical Pharmacology·Flavia RadognaLina Ghibelli
Jan 27, 2011·Neuroreport·Kellie K BowenRaghu Vemuganti
Mar 12, 2011·Journal of Pineal Research·Xiao-Jing LinMao-Tsun Lin
Jul 15, 2011·Journal of Pineal Research·Annia GalanoRussel J Reiter
Mar 1, 2012·Current Pharmaceutical Design·Armen Yuri Gasparyan
Sep 3, 2013·Current Neuropharmacology·Sheng-Hsien ChenChing-Ping Chang
Nov 19, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rui JiQingxian Lu
Aug 15, 2015·Journal of Pineal Research·Lucien C ManchesterRussel J Reiter
Nov 7, 2015·Drug Design, Development and Therapy·Engin Burak SelçukBurcu Kayhan-Tetik
Apr 14, 2016·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Mukesh KumarMangala Lahkar
Aug 9, 2016·Journal of Pineal Research·Russel J ReiterLilian Qin

❮ Previous
Next ❯

Citations

Jun 4, 2021·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Je-Ming HuYen-Mei Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.